Jae-Weon Kim

发表

Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG)

Joo Hyun Park, J. Hong, Jayeon Kim, 2018, Obstetrics & gynecology science.

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study

D. Suh, M. Lim, Tae Hun Kim, 2022, BMC cancer.

Safety and feasibility of laterally extended endopelvic resection for sarcoma in the female genital tract: a prospective cohort study

S. Park, G. Yim, HeeSeung Kim, 2022, Obstetrics & gynecology science.

Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening

S. I. Kim, Jae-Weon Kim, 2022, Journal of gynecologic oncology.

Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.

H. Chung, N. Park, Y. Song, 2022, Gynecologic oncology.

Impact of bevacizumab and secondary cytoreductive surgery on survival outcomes in platinum-sensitive relapsed ovarian clear cell carcinoma: A multicenter study in Korea.

Jeong-Won Lee, Kidong Kim, J. Park, 2022, Gynecologic oncology.

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial

C. Choi, Byoung-Gie Kim, Sunghoon Kim, 2022, Journal of gynecologic oncology.

Major clinical research advances in gynecologic cancer in 2021

Y. Lee, J. Park, Jung-Yun Lee, 2022, Journal of gynecologic oncology.

Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study

Jae-Weon Kim, H. Watari, Byoung-Gie Kim, 2017, Cancer.

Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea.

Jeong-Won Lee, Jung-Yun Lee, S. I. Kim, 2022, Gynecologic oncology.

Final overall survival results from SOLO3: Phase III trial assessing olaparib monotherapy versus non-platinum chemotherapy in heavily pretreated patients with germline BRCA1 - and/or BRCA2-mutated platinum-sensitive relapsed ovarian cancer (026)

N. Colombo, G. Scambia, E. Lowe, 2022, Gynecologic Oncology.

Asian Young Doctors Session at the 64th Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO): Educational Initiatives in the Next Generation for a New Era after the COVID-19 Pandemic

K. Ushijima, Yusuke Kobayashi, Chia-Sui Weng, 2022, Journal of gynecologic oncology.

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology

Joo Hyun Park, J. Hong, Jayeon Kim, 2020, Obstetrics & gynecology science.

Asian Society of Gynecologic Oncology International Workshop 2014

H. Chung, H. Ngan, Jeong-Won Lee, 2015, Journal of gynecologic oncology.

Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R).

C. Choi, Maria Lee, Daeyeon Kim, 2023, Gynecologic oncology.

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010

Kyu-Won Jung, K. Jung, Y. Won, 2013, Journal of gynecologic oncology.

Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses

J. Choi, Min Ji Park, Suhwan Chang, 2021, medRxiv.

Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition

Jae Kwan Lee, H. Chung, Jae-Weon Kim, 2013, Journal of gynecologic oncology.

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer

Jeong-Won Lee, C. Choi, Byoung-Gie Kim, 2021, Cancer science.

Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis

M. Lim, S. I. Kim, Jae-Weon Kim, 2023, Gynecologic Oncology.

Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.

Sunghoon Kim, Junsik Park, H. Kim, 2024, Gynecologic oncology.

Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D

C. Choi, Sunghoon Kim, Junsik Park, 2023, Journal for ImmunoTherapy of Cancer.